CLEVELAND BIOLABS INC·4

Apr 5, 8:47 PM ET

Viallet Jean 4

4 · CLEVELAND BIOLABS INC · Filed Apr 5, 2013

Insider Transaction Report

Form 4
Period: 2013-04-03
Viallet Jean
Chief Development Officer
Transactions
  • Award

    Stock Option (right to buy)

    2013-04-03+100,000100,000 total
    Exercise: $2.04Exp: 2023-04-03Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option becomes exercisable in four equal installments on the following dates: April 4, 2013, April 1, 2014, April 1, 2015 and April 1, 2016. 25,000 shares underlying the option are currently exercisable.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES